Selecting the Most Appropriate Disease Specific Capsids for your Gene Therapy Product
Time: 1:30 pm
day: Conference Day Two
Details:
- Outlining the landscape of research vectors
- Utilising clinically approved vectors for delivery to the CNS
- Looking at insights into the future landscape of gene therapy for neurological disorders
